EA200300537A1 - Антагонисты гистаминовых рецепторов - Google Patents

Антагонисты гистаминовых рецепторов

Info

Publication number
EA200300537A1
EA200300537A1 EA200300537A EA200300537A EA200300537A1 EA 200300537 A1 EA200300537 A1 EA 200300537A1 EA 200300537 A EA200300537 A EA 200300537A EA 200300537 A EA200300537 A EA 200300537A EA 200300537 A1 EA200300537 A1 EA 200300537A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antagonists
receptor antagonist
histamine
histamine receptors
combination
Prior art date
Application number
EA200300537A
Other languages
English (en)
Russian (ru)
Inventor
Стивен Дженкинсон
Марк Энтони О'Рэйли
Майкл Эндрю Триветик
Original Assignee
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк. filed Critical Пфайзер Инк.
Publication of EA200300537A1 publication Critical patent/EA200300537A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA200300537A 2001-01-17 2002-01-10 Антагонисты гистаминовых рецепторов EA200300537A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists
PCT/IB2002/000042 WO2002056871A2 (en) 2001-01-17 2002-01-10 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
EA200300537A1 true EA200300537A1 (ru) 2004-02-26

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300537A EA200300537A1 (ru) 2001-01-17 2002-01-10 Антагонисты гистаминовых рецепторов

Country Status (31)

Country Link
EP (1) EP1353657A1 (es)
JP (1) JP2004517883A (es)
KR (1) KR20030069216A (es)
CN (1) CN1486178A (es)
AP (1) AP2002002401A0 (es)
AR (1) AR032101A1 (es)
BG (1) BG107834A (es)
BR (1) BR0206502A (es)
CA (1) CA2435121A1 (es)
CR (1) CR6983A (es)
CZ (1) CZ20031853A3 (es)
DO (1) DOP2002000325A (es)
EA (1) EA200300537A1 (es)
EC (1) ECSP034692A (es)
EE (1) EE200300335A (es)
GB (1) GB0101223D0 (es)
GT (1) GT200200003A (es)
HU (1) HUP0302767A2 (es)
IL (1) IL156087A0 (es)
IS (1) IS6818A (es)
MA (1) MA26980A1 (es)
MX (1) MXPA03006408A (es)
NO (1) NO20033223D0 (es)
OA (1) OA12440A (es)
PA (1) PA8537101A1 (es)
PL (1) PL362793A1 (es)
SK (1) SK8572003A3 (es)
SV (1) SV2003000849A (es)
TN (1) TNSN02003A1 (es)
WO (1) WO2002056871A2 (es)
ZA (1) ZA200304180B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
MXPA05002577A (es) * 2002-09-06 2005-09-20 Johnson & Johnson Uso de moduladores del receptor h4 de histamina para el tratamiento de alergia y asma.
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
HUE039713T2 (hu) 2012-06-08 2019-02-28 Sensorion H4 receptor inhibitorok tinnitus kezelésére

Also Published As

Publication number Publication date
NO20033223L (no) 2003-07-16
CN1486178A (zh) 2004-03-31
BR0206502A (pt) 2003-10-21
SV2003000849A (es) 2003-01-13
HUP0302767A2 (hu) 2003-11-28
CR6983A (es) 2003-11-25
GT200200003A (es) 2002-08-19
AR032101A1 (es) 2003-10-22
SK8572003A3 (en) 2004-07-07
MA26980A1 (fr) 2004-12-20
ZA200304180B (en) 2004-06-15
MXPA03006408A (es) 2003-10-15
PL362793A1 (en) 2004-11-02
OA12440A (en) 2006-05-22
EP1353657A1 (en) 2003-10-22
TNSN02003A1 (fr) 2005-12-23
WO2002056871A2 (en) 2002-07-25
IL156087A0 (en) 2003-12-23
NO20033223D0 (no) 2003-07-16
KR20030069216A (ko) 2003-08-25
IS6818A (is) 2003-05-15
BG107834A (bg) 2004-01-30
ECSP034692A (es) 2003-08-29
CA2435121A1 (en) 2002-07-25
AP2002002401A0 (en) 2002-03-31
PA8537101A1 (es) 2002-08-29
CZ20031853A3 (cs) 2004-07-14
EE200300335A (et) 2003-12-15
DOP2002000325A (es) 2003-01-31
GB0101223D0 (en) 2001-02-28
JP2004517883A (ja) 2004-06-17

Similar Documents

Publication Publication Date Title
DE60215000D1 (de) DIHYDROPYRROLOi1,2-AöINDOL- UND TETRAHYDROPYRIDOi1,2-AöINDOLDERIVATE ALS PROSTAGLANDIN REZEPTOR ANTAGONISTEN
ATE479686T1 (de) Pyridopyrrolizin- und pyridoindolizinderivate
UA74419C2 (uk) Заміщені піридини та їх застосування як антагоністів рецептору метаботропного глутамату
WO2004082602A3 (en) Carboxamide spirohydantoin cgrp receptor antagonists
WO2004022537A3 (en) Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
DE69508093T2 (de) Substituierte piperidine für die behandlung von allergischen krankheiten
WO2005103041A3 (en) Treatment of cns disorders using cns target modulators
ATE464304T1 (de) Carboxamid-spirolactam-cgrp-rezeptor-antagonist n
WO2004082605A3 (en) Bicyclic anilide spirohydantoin cgrp receptor antagonists
WO2004087649A3 (en) Benodiazepine spirohydantoin cgrp receptor antagonists
ATE515513T1 (de) Behandlung von fibrose durch antagonismus zwischen il-13 und il-13-rezeptorketten
ATE540944T1 (de) Pyridylpiperidinorexin-rezeptorantagonisten
WO2007067511A3 (en) Morpholine carboxamide prokineticin receptor antagonists
DE60228073D1 (de) Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen
IS8377A (is) Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
DE60038686D1 (de) Oheptan-derivate und ihre verwendung als integrin-rezeptor-antagonisten
DE502004011551D1 (de) 1,3,4-substituierte pyrazole als 5-ht rezeptor-antagonisten zur behandlung von psychosen und neurologischen störungen
EA200300040A1 (ru) 1-аминоалкилциклогексаны в качестве антагонистов 5-нт3 и нейрональных никотиновых рецепторов
EA200300537A1 (ru) Антагонисты гистаминовых рецепторов
WO2004066960A3 (en) Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
WO2004014847A8 (en) Mcp-1 receptor antagonists and method of use thereof
ATE454153T1 (de) 5-ht4 antagonisten zur behandlung von herzversagen
MXPA04007026A (es) Pirimidinonas y pirimidintionas sustituidas.
WO2005063697A3 (en) Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders
ATE396996T1 (de) Selektive d1/d5 rezeptorantagonisten zur behandlung von fettleibigkeit und von zns störungen